Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-24 Sale | 2025-11-25 6:40 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 41,163 | $18.86 | $776,429 | 545,999 (Direct) | View |
| 2025-10-16 Sale | 2025-10-20 4:11 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $18.83 | $453,761 | 587,162 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 6:00 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $18.88 | $466,936 | 925,927 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-04 4:37 pm | N/A 2036-02-02 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-18 6:02 pm | N/A 2033-12-14 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 29,500 | $0 | 904,904 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-18 6:02 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 29,500 | $5.4537 | 904,904 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-25 6:40 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 41,163 | $0 | 545,999 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-25 6:40 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 41,163 | $3.7898 | 545,999 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 4:11 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $0 | 587,162 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 4:11 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,103 | $3.7898 | 587,162 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 6:00 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $0 | 925,927 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-15 6:00 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 24,734 | $3.7898 | 925,927 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:16 pm | N/A 2035-06-08 | Relay Therapeutics Inc. | RLAY | Mazumdar Claire Director | 421,241 | $0 | 421,241 (Direct) | View |
Ownership | 2024-09-12 9:09 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 0 | $0 | 2,674,577 (Direct) | View |